I tossed and turned all night after I read the FDA's warning about increased risk of suicidal behaviour with the use of Lyrica. After all, it's been one of the choice drugs for the treatment of fibromyalgia for quite some time. When I went back to work in January I asked my colleagues what they thought about the warning. None of them had heard of it. I asked a colleague who does fibromyalgia research and prescribes Lyrica by the truck-load. Hadn't heard a thing. Then it dawned on me. Here in Canada we don't get FDA warnings. If you don't read blogs or read American news, you'd never be aware of the warning. So then I had to wonder; what are my legal and ethical obligations regarding this matter? Legally I imagine I'm off the hook. If Health Canada is good with a drug, I can't see a problem. But ethically, can I ignore the warnings of the FDA. With it's relatively massive resources, the FDA has studied and concluded that there is a problem. Health Canada may never get around to looking into the matter. Makes sense that I should consider the FDA as a reliable source and act accordingly. But if this is the case, am I, as a Canadian, obliged to keep up with all the wisdom arising from below the 49th and treat it as my own? And the Europeans aren't exactly slouches over there. Must I keep abreast of all things brewing at the European Medicines Agency , or the UK's NICE. Should I learn how to speak Australian. so I can get info from the Australian TGA. Maybe so.